![](https://investorshub.advfn.com/uicon/383258.png?cb=1471585452)
Saturday, January 23, 2016 10:13:44 AM
"Regen is a public company so it can raise money in the capitol markets, a fact that could soon be lucrative for the local biotech firm.
“We believe that sometime in the first half of 2016 we should have an IND filed on our small molecule and companies with an IND filed tend to be worth north of half a billion dollars.” "
And this
“Ideally, designing some of these new immuno-oncology drugs that are actually small molecules would be sort of a Holy Grail for the insurance companies; for biopharma; and for the patients,” said Lander. “If we can develop a drug that is as effective or more effective than the current biologics –– that is small molecule and therefore much cheaper –– that would be wonderful. People would have access to it all over the world and not just the United States.”
http://lamesacourier.com/la-mesas-atypical-biotech-firm/
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM